Clinical Trial Update: Study of SAF312 as an Eye Drop for Treatment of Eye Pain Following Photorefractive Keratectomy (PRK) Surgery [Phase 2]

View source ↗

Summary

Phase 2 study of SAF312 eye drops for postoperative ocular pain after PRK surgery completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Ocular Pain After Prk Surgery

Drugs mentioned

• SAF312

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Postoperative Ocular Pain After PRK Surgery | Phase 2 | Status: COMPLETED | Results posted: 2019-04-11